Domov › Shizofrenija › Kalifornija
Klinične študije za Shizofrenija v Kalifornija
45 študij za Shizofrenija išče udeležence na lokacijah v Kalifornija.
Mesta v Kalifornija
- San Diego13 študij
- Garden Grove12 študij
- Inglewood8 študij
- Anaheim8 študij
- Los Angeles8 študij
- El Cajon8 študij
- Orange7 študij
- Downey6 študij
- Chino6 študij
- Oceanside6 študij
- Torrance6 študij
- Riverside6 študij
- Mountain View5 študij
- Westminster5 študij
- Bellflower4 študij
- Norwalk4 študij
- San Francisco3 študij
- San Bernardino3 študij
- Concord3 študij
- Fullerton3 študij
- Ontario3 študij
Uradno besedilo študije (angleško)
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- University of California, Irvine, Irvine
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–59 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07853807Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- ATP Clinical Research - Costa Mesa, Orange
- Lumos Clinical Research Center, San Jose
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07101094A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- CNS Network, Garden Grove
Vključevanje udeležencevFaza 1
Starost 18–55 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07615426Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0190, Anaheim
- Local Institution - 0040, Bellflower
- Local Institution - 0188, Chino
- in še 10
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Advanced Research Center, Inc, Anaheim
- National Institute Of Clinical Research, Garden Grove
- Excell Research Inc, Oceanside
- in še 3
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Culver City
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, Riverside
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07105098NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Cerritos
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Culver City
- in še 9
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, La Habra
- Neurocrine Clinical Site, Lemon Grove
- in še 2
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Advanced Research Center Inc., Anaheim
- Local Institution - 0159, Anaheim
- Inland Psychiatric Medical Group., Chino
- in še 7
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Collaborative Neuroscience Research, LLC, Garden Grove
- Catalina Research Institute, LLC, Montclair
- in še 3
Vključevanje udeležencevFaza 2
Starost 18–55 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Fresno
- Neurocrine Clinical Site, Long Beach
- in še 3
Vključevanje udeležencevFaza 4
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Collaborative Neuroscience Research, LLC, Los Alamitos
Vključevanje udeležencevFaza 1
Starost 18–55 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- California Clinical Trials Medical Group - Parexel /ID# 275751, Glendale
- CenExel Collaborative Neuroscience Research /ID# 273005, Los Alamitos
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
- Advanced Research Center, Anaheim
- Synapse Clinical Trials, Cerritos
- ProScience Research Group, Culver City
- in še 2
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- Advanced Research Center Inc., Anaheim
- Inland Psychiatric Medical Group., Chino
- Proscience Research Group, Culver City
- in še 1
Vključevanje udeležencevFaza 3
Starost 13–17 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07288567A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Collaborative Neuroscience Research, LLC, Los Alamitos
Vključevanje udeležencevFaza 1
Starost 18–55 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Bellflower
- Clinical Site, Cerritos
- Clinical Site, Culver City
- in še 12
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Pamoja Advanced Nursing Practice, Anaheim
- Local Institution - 0003, Anaheim
- Inland Psychiatric Medical Group (IPMG)-Chino, Chino
- in še 3
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT07379827Enhancing Veteran-Clinical Collaboration in VA PRRCs
- VA San Diego Healthcare System, San Diego, CA, San Diego
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT06898879Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Stanford
Vključevanje udeležencevFaza 3
Starost 10–17 · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT05303064Inter-Brain Synchrony in Schizophrenia
- University of California, Los Angeles, Los Angeles
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT07177261Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
- BioXcel Clinical Research Site, Anaheim
Vključevanje udeležencevFaza 1
Starost 10–17 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT05025605Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
- UCLA Aftercare Research Program, Los Angeles
Vključevanje udeležencev
Starost 18–45 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT05890183Biomarkers to Enhance Early Schizophrenia Treatment
- University of California San Diego, La Jolla
Vključevanje udeležencevFaza 4
Starost 18–35 · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT06969755Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
- CNRI Los Angeles LLC, Pico Rivera
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT07467993Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- ProScience Research Group, Culver City
- CenExel, Garden Grove
- Synergy San Diego, Lemon Grove
- in še 1
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07363577Tolerability of MDMA in Schizophrenia
- UCLA, Los Angeles
Vključevanje udeležencevFaza 1/2
Starost 18–60 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT05770375Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
- Acacia Clinics, Sunnyvale
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 16. jul. 2026 · NCT06376734A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Synapse Clinical Trials, Cerritos
- Synergy Research Center, Lemon Grove
- Cenexel CNS, Los Alamitos
Vključevanje udeležencevFaza 2
Starost 18–55 · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Clinical Innovations, Inc. dba CITrials, Bellflower
- CenExel CNS - Garden Grove, Garden Grove
- ATP Clinical Research, Orange
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT07221877Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
- University of California, Los Angeles, Los Angeles
Vključevanje udeležencevFaza 4
Starost 18–65 · Vsi spoli · Posodobljeno 4. maj 2026 · NCT05208190Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
- UCLA Semel Institute, Los Angeles
Vključevanje udeležencevFaza 2
Starost 18–60 · Vsi spoli · Posodobljeno 28. apr. 2026 · NCT05778591Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
- Imaging Research Center, Sacramento
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–47 · Vsi spoli · Posodobljeno 30. mar. 2026 · NCT04267003NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Anaheim
- Neurocrine Clinical Site, Pico Rivera
- Neurocrine Clinical Site, San Diego
- in še 2
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 6. mar. 2026 · NCT06963034Brain Stimulation to the Hippocampus in Schizophrenia
- Stanford University, Stanford
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT07010614Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
- University of California - San Diego, San Diego
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 23. feb. 2026 · NCT06865937Enhancing Rehabilitation for Veterans With Serious Mental Illness
- VA San Diego Healthcare System, San Diego, CA, San Diego
Vključevanje udeležencev
Starost 18–83 · Vsi spoli · Posodobljeno 30. jan. 2026 · NCT06586164Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
- UC San Diego, San Diego
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 23. jan. 2026 · NCT07098169Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
- Collaborative Neuroscience Research, LLC - CenExel, Los Alamitos
Vključevanje udeležencevZgodnja faza 1Vabljeni zdravi prostovoljci
Starost 18–55 · Vsi spoli · Posodobljeno 15. jan. 2026 · NCT07344948Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Costa Mesa
- Vanda Investigational Site, Lemon Grove
- Vanda Investigational Site, Oceanside
- in še 3
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 12. jan. 2026 · NCT06961968Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.